FGFR2 and gastric cancer: Specifically, amplification of the FGFR2 gene stands out as the predominant anomaly within the FGFR2 gene, particularly influencing GCaGC and especially its diffuse form, which comprises more than one-third of all GC cases [2,10,11,12].